InspireMD, Inc. (NSPR)
InspireMD, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Miami, FL, US. The stock last traded at $0.86, up 0.87% on the session, giving a market capitalisation of $40.3M. On trailing twelve-month figures it carries a trailing P/E of -1.52, a net margin of -344.1%. Its beta of 0.77 implies it has historically moved less than the broad market.
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
InspireMD, Inc. is most often compared with the following Healthcare names: